Robeco Institutional Asset Management B.V. Prothena Corp Public LTD CO Transaction History

Robeco Institutional Asset Management B.V.

  • $51.9 Billion
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 26, 2022
SELL
$30.27 - $49.22 $663,881 - $1.08 Million
-21,932 Closed
0 $0
Q4 2021

Dec 01, 2022
BUY
$42.11 - $73.26 $209,370 - $364,248
4,972 Added 29.32%
21,932 $1.08 Million
Q4 2021

Jan 31, 2022
BUY
$42.11 - $73.26 $209,370 - $364,248
4,972 Added 29.32%
21,932 $1.08 Million
Q3 2021

Dec 01, 2022
BUY
$48.2 - $78.89 $817,472 - $1.34 Million
16,960 New
16,960 $1.21 Million
Q3 2021

Oct 20, 2021
BUY
$48.2 - $78.89 $817,472 - $1.34 Million
16,960 New
16,960 $1.21 Million

Others Institutions Holding PRTA

# of Institutions
198
Shares Held
44.5M
Call Options Held
601K
Put Options Held
259K
View Full List

About PROTHENA CORP PUBLIC LTD CO

PRTA Quotes by TradingView
  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $701M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Robeco Institutional Asset Management B.V. Portfolio

Follow Robeco Institutional Asset Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email